Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Hoth Therapeutics (NASDAQ: HOTH) Advances Antisense Oligonucleotide Cancer Drug Candidate HT-KIT

Hoth Therapeutics, Inc. (NASDAQ: HOTH) has announced significant progress in the development of its proprietary antisense oligonucleotide (ASO) drug candidate, HT-KIT. The biopharmaceutical company is focused on creating therapies for allergic and inflammatory diseases, and HT-KIT represents an innovative approach to treating conditions such …

Team Kalkine | 26 March 2025

V2X (NYSE: VVX) Awarded Bridge to Enduring Synthetic Training Environment Contract with U.S. Army

V2X Inc. (NYSE: VVX) has been selected as a winner for the Bridge to Enduring Synthetic Training Environment Tactical Engagement Simulation Systems (TESS) Multiple-Award Contract (BEST MAC) Lot 1. This contract is a key component of the U.S. Army’s live training capabilities, as it …

Team Kalkine | 26 March 2025

Faraday Future (Nasdaq: FFAI) Expands to New York with FF 91 2.0 Futurist Alliance

Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI), a global electric mobility ecosystem company, has announced its official entry into the East Coast market with the delivery of its flagship FF 91 2.0 Futurist Alliance vehicle in New York City on March 28. This marks …

Team Kalkine | 26 March 2025

Box, Inc. (NYSE: BOX) Partners with Swissport for Secure Content Management Platform

Box, Inc. (NYSE: BOX), a leader in Intelligent Content Management (ICM), has been selected by Swissport International AG as its unified platform for secure content management. Swissport, a global provider of aviation services, operates in 45 countries with over 60,000 employees. With a large …

Team Kalkine | 26 March 2025

Titan America (NYSE: TTAM) Reports Modest Increase in 2024 Revenue to USD1.63Bn

Titan America SA (NYSE: TTAM), a prominent producer of building materials and services along the U.S. East Coast, has reported its financial results for the fourth quarter and full-year 2024. The company, including its operating subsidiary Titan America LLC, generated revenue of $1.63 billion …

Team Kalkine | 26 March 2025

Daily Market Recap: Indices, Futures, and Economic Developments

Trump suggested some April 2 tariffs may be reduced or exempted but proposed new tariffs on autos, pharmaceuticals, and Venezuelan crude buyers. Atlanta Fed’s Bostic forecasted one 25bps rate cut in 2024, while the Fed signaled two for 2025. Tesla rose despite EU sales …

Team Kalkine | 25 March 2025

NuScale Power Opens Energy Exploration Center at Rensselaer Polytechnic Institute

NuScale Power Corporation (NYSE:SMR), a leader in small modular reactor (SMR) nuclear technology, has announced the opening of an Energy Exploration (E2) Center at Rensselaer Polytechnic Institute (RPI) in Troy, New York. The new training facility will offer RPI engineering students a first-hand experience …

Team Kalkine | 25 March 2025

Cognizant Expands AI Capabilities with NVIDIA Partnership to Drive Cross-Industry Innovation

Cognizant (NASDAQ:CTSH) has unveiled a series of AI advancements powered by NVIDIA technology, aimed at accelerating AI adoption across various industries. The initiative focuses on five key areas: enterprise AI agents, industry-specific large language models (LLMs), digital twins for smart manufacturing, foundational AI infrastructure, …

Team Kalkine | 25 March 2025

New Found Gold Unveils Initial Mineral Resource Estimate for Queensway Project

New Found Gold Corp. (TSXV:NFG, NYSE-A:NFGC) has announced its initial Mineral Resource Estimate (MRE) for the Queensway Gold Project, located in Newfoundland and Labrador, Canada. The estimate outlines an Indicated Mineral Resource of 18.0 million tonnes grading 2.40 grams per tonne (g/t) of gold, …

Team Kalkine | 25 March 2025

Entero Therapeutics Announces Rescission Agreement and New CFO Appointment

Entero Therapeutics, Inc. (NASDAQ:ENTO), a clinical-stage biopharmaceutical company specializing in targeted therapies for gastrointestinal diseases, has successfully reached an agreement to rescind its previously completed business combination with ImmunogenX, LLC. The rescission agreement, signed with all former ImmunogenX shareholders, is subject to certain conditions, …

Team Kalkine | 24 March 2025
Support

Hi! How can we help you today?

Loading…